Elizabeth Woo | SVP, IR and Corporate Communications |
Bill McVicar | CEO |
Tom Wessel | CMO |
Mara Goldstein | Cantor Fitzgerald |
Michael Higgins | ROTH Capital Partners |
Roger Tung | Jefferies |
Good day, ladies and gentlemen, and welcome to the Flex Pharma Call to discuss ALS Data and Q3 Business Update. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions].
As a reminder, this conference is being recorded.